BioTime, Inc. Announces The Formation Of Embryome Sciences, Inc. For The Development And Commercialization Of Stem Cell Technology

BioTime, Inc. (OTCBB:BTIM) announced that it has organized a new subsidiary, Embryome Sciences, Inc. The mission of the new company is to participate in the emerging field of regenerative medicine known as “embryomics”. “Human embryonic stem cells are capable of becoming all of the thousands of different cell types in the body,” said Michael West, Ph.D., Chief Executive Officer. [click link for full article]

More: continued here

Filed under: Stem Cell Research on December 15th, 2007